|

CAR-T Cell Injection Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Zhimin Zhai1

Indications

  • CAR-T1
  • Acute Myeloid Leukemia (AML)1
  • Cancer1

Other1 trial

EX02 CAR-T Cells for Relapsed and Refractory Acute Myeloid Leukemia
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.